home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

West Pharmaceutical Services, Inc. Common Stock (NY:WST)

274.98 +3.15 (+1.16%)

Official Closing Price Updated: 7:00 PM EST, Jan 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about West Pharmaceutical Services, Inc. Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years ↗

July 25, 2023

Via Benzinga

Worried About Market Froth? Buy These 3 Dividend Stocks ↗

July 22, 2023

If you are concerned about the massive rallies in tech leading to sharp corrections, then taking profits or adding other positions could be a prudent move. One place to look for solace when the broader...

Via Talk Markets

West Pharmaceutical Servs: Dividend Insights ↗

July 20, 2023

Via Benzinga

How Is The Market Feeling About West Pharmaceutical Servs? ↗

July 14, 2023

Via Benzinga

$1000 Invested In West Pharmaceutical Servs 20 Years Ago Would Be Worth This Much Today ↗

July 12, 2023

Via Benzinga

P/E Ratio Insights for West Pharmaceutical Servs ↗

July 10, 2023

Via Benzinga

10 Safest Dividend Aristocrats For 2023 ↗

July 02, 2023

A company cannot pay rising dividends for 25+ years without having a strong and durable competitive advantage. But some Dividend Aristocrats are better than others, based on the sustainability of their...

Via Talk Markets

$1000 Invested In This Stock 20 Years Ago Would Be Worth $62,000 Today ↗

June 29, 2023

Via Benzinga

Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years ↗

June 13, 2023

Via Benzinga

Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years ↗

May 29, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023 ↗

June 16, 2023

Via Benzinga

NVIDIA To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Friday ↗

June 16, 2023

Raymond James boosted the price target for Jabil Inc. (NYSE: JBL) from $100 to $120. Raymond James analyst Melissa Fairbanks maintained a Strong Buy rating. Jabil shares rose 5% to close at $104.64 on...

Via Benzinga

3 ETFs to Buy for Stress-Free Profits ↗

May 24, 2023

These stress-free ETFs won't fluctuate a great deal and can be relied upon to deliver profits in the medium-term and the long-term.

Via InvestorPlace

$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,000 Today ↗

May 11, 2023

Via Benzinga

Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 5 Years ↗

April 20, 2023

Via Benzinga

West Pharmaceutical Servs: Dividend Insights ↗

April 20, 2023

Via Benzinga

West Pharmaceutical Servs Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗

April 18, 2023

Via Benzinga

3 Overvalued S&P 500 Stocks to Dump Now ↗

May 03, 2023

Investors should consider taking profits on these overvalued S&P 500 stocks now with a potential recession on the horizon.

Via InvestorPlace

7 Dividend Aristocrats to Buy for Long-Term Income ↗

April 28, 2023

These dividend aristocrats are the best stocks to buy for long-term income generation and lower portfolio risk.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2023 ↗

April 11, 2023

Via Benzinga

$100 Invested In West Pharmaceutical Servs 5 Years Ago Would Be Worth This Much Today ↗

April 05, 2023

Via Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,000 Today ↗

March 29, 2023

Via Benzinga

A Bullish Sign Appears On West Pharmaceutical Servs's Chart ↗

March 13, 2023

Via Benzinga

Earnings Scheduled For April 27, 2023 ↗

April 27, 2023

Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is expected to report earnings for its first quarter.

Via Benzinga

Analyst Says West Pharmaceutical Services Is 'Expensive But For Good Reason' ↗

April 11, 2023

Via Benzinga

What Factors Will Drive S&P 500 Performance This Year?

April 07, 2023

Analysts are forecasting a positive return for the S&P 500, and back-to-back downside years are rare. But weakening earnings could put a dent in returns.

Via MarketBeat

Topics ETFs Stocks

Healthcare Stocks With at Least 30 Years of Dividend Increases

March 14, 2023

Among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield.

Via MarketBeat

Analyst Views West Pharmaceutical's Q4 Earnings Impressive Despite Headwinds ↗

February 16, 2023

Via Benzinga

KBR, Twilio, Roku And Other Big Stocks Moving Higher On Thursday ↗

February 16, 2023

U.S. stocks traded lower, with the Dow Jones dropping over 250 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 16, 2023

Gainers TravelCenters of America Inc. (NASDAQ: TA) shares jumped 70.5% to $84.32 after BP announced it will acquire the company for $86 per share in cash.

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com